Increasing productivity in biopharma R&D

The Gyrolab® platform uses groundbreaking technology to automate immunoassays at nanoliter scale, so you reach your laboratory goals faster and deliver results that make a difference.

WEBINAR: Overcoming matrix interference: ADA immunoassays using an automated nanoliter platform

WEBINAR: Overcoming matrix interference: ADA immunoassays using an automated nanoliter platform

Learn how Sally Ye, Sr. Scientist, DMPK, Boehringer Ingelheim Pharmaceuticals, Inc, reduced matrix interference in clinical ADA assays.

View on demand

Accelerating time to insight

Using an affinity flow-through format, highly reproducible nanoliter microfluidics, and parallel processing, the Gyrolab platform transforms immunoassay workflows and shortens run times by automating assay steps, improving data quality.

Whether you’re looking for a complete system, a kit, or components, Gyrolab platforms miniaturize, integrate, and automate sample analysis at scale, maximizing your productivity and helping your lab make data-driven decisions – fast.

Improving bioanalysis workflows

Proprietary Gyrolab technology simplifies assay workflows by eliminating incubations and shortening run times.


Reaching biologics development goals faster

Our highly experienced scientists understand the best approaches to optimize your processes, remove obstacles to your work, and help you reach your goals faster.

Subscribe to the immunoassay's newsletter
YouTube
Follow us on LI